dCas9-FCPF
(Plasmid
#220131)
-
PurposeExpresses dCas9-FCPF in mammalian cells
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 220131 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3.1
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 5369
- Total vector size (bp) 9665
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namedCas9-FCPF
-
SpeciesSynthetic; S. pyogenes
-
GenBank IDWP_010922251.1
-
Entrez Genecas9 (a.k.a. SD90_RS03825, SD90_03830)
- Promoter CMV
-
Tags
/ Fusion Proteins
- HA (C terminal on insert)
- Flag (N terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BstEII (not destroyed)
- 3′ cloning site Xbal (not destroyed)
- 5′ sequencing primer CMV (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byGenscript
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
dCas9-FCPF was a gift from Xinlai Cheng (Addgene plasmid # 220131 ; http://n2t.net/addgene:220131 ; RRID:Addgene_220131) -
For your References section:
Chem-CRISPR/dCas9FCPF: a platform for chemically induced epigenome editing. Altinbay M, Wang J, Chen J, Schafer D, Sprang M, Blagojevic B, Wolfl S, Andrade-Navarro MA, Dikic I, Knapp S, Cheng X. Nucleic Acids Res. 2024 Sep 24:gkae798. doi: 10.1093/nar/gkae798. 10.1093/nar/gkae798 PubMed 39315698